N-terminal-pro-B-type-natriuretic peptide associated with 2-year mortality from both cardiovascular and non-cardiovascular origins in prevalent chronic hemodialysis patients

References

• Stenvinkel P, Carrero JJ, Axelsson J, et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol. 2008;3:505–521.
   PubMed Web of Science ®Google Scholar
• Flythe JE, Inrig JK, Shafi T, et al. Association of intradialytic blood pressure variability with increased all-cause and cardiovascular mortality in patients treated with long-term hemodialysis. Am J Kidney Dis. 2013;61:966–974.
   PubMed Web of Science ®Google Scholar
• Selvarajah V, Pasea L, Ojha S, et al. Pre-dialysis systolic blood pressure-variability is independently associated with all-cause mortality in incident haemodialysis patients. PLoS One. 2014;9:e86514.
   PubMed Web of Science ®Google Scholar
• Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208–2218.
   PubMed Web of Science ®Google Scholar
• Jean G, Terrat JC, Vanel T, et al. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transplant. 2009;24:2792–2796.
   PubMed Web of Science ®Google Scholar
• Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int. 1998;54:627–636.
   PubMed Web of Science ®Google Scholar
• Zimmermann J, Herrlinger S, Pruy A, et al. Inflamma-tion enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648–658.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Regidor DL, Kovesdy CP, et al. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 2009;119:671–679.
   PubMed Web of Science ®Google Scholar
• Hung SC, Kuo KL, Peng CH, et al. Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease. Kidney Int. 2014;85:703–709.
   PubMed Web of Science ®Google Scholar
• Hunt PJ, Richards AM, Nicholls MG, et al. Immuno-reactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol. 1997;47:287–296.
   PubMed Web of Science ®Google Scholar
• Fisher C, Berry C, Blue L, et al. N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure. Heart 2003;89:879–881.
   PubMed Web of Science ®Google Scholar
• Morrow DA, Cannon CP, Jesse RL, et al. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007;115:e356–e375.
   PubMedGoogle Scholar
• Trimarchi H, Muryan A, Dicugno M, et al. In hemodialysis, adiponectin, and pro-brain natriuretic peptide levels may be subjected to variations in body mass index. Hemodial Int. 2011;15:477–484.
   PubMed Web of Science ®Google Scholar
• Paniagua R, Ventura MD, Avila-Díaz M, et al. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant. 2010;25:551–557.
   PubMed Web of Science ®Google Scholar
• Khan IA, Fink J, Nass C, et al. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients. Am J Cardiol. 2006;97:1530–1534.
   PubMed Web of Science ®Google Scholar
• Satyan S, Light RP, Agarwal R. Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis. 2007;50:1009–1019.
   PubMed Web of Science ®Google Scholar
• David S, Kümpers P, Seidler V, et al. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. Nephrol Dial Transplant. 2008;23:1370–1377.
   PubMed Web of Science ®Google Scholar
• Madsen LH, Ladefoged S, Corell P, et al. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int. 2007;71:548–554.
   PubMed Web of Science ®Google Scholar
• Guo Q, Bárány P, Qureshi AR, et al. N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients. Am J Nephrol. 2009;29:516–523.
   PubMed Web of Science ®Google Scholar
• Sato Y, Fujimoto S, Toida T, et al. Apoprotein B/Apoprotein A-1 ratio and mortality among prevalent dialysis patients. Clin J Am Soc Nephrol. 2016;11:840–846.
   PubMed Web of Science ®Google Scholar
• Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007;96:644–647.
   PubMed Web of Science ®Google Scholar
• Winkler K, Wanner C, Drechsler C, et al. Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients. Eur Heart J. 2008;29:2092–2099.
   PubMed Web of Science ®Google Scholar
• Booth J, Pinney J, Davenport A. N-terminal proBNP-marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol. 2010;5:1036–1040.
   PubMed Web of Science ®Google Scholar
• Iwasaki M, Joki N, Tanaka Y, et al. Efficacy of N-terminal pro-brain natriuretic peptide digit number for screening of cardiac disease in new haemodialysis patients. Nephrology (Carlton). 2013;18:497–504.
   PubMed Web of Science ®Google Scholar
• Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001;39:571–588.
   PubMed Web of Science ®Google Scholar
• Hogenhuis J, Voors AA, Jaarsma T, et al. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP. Eur J Heart Fail. 2005;7:81–86.
   PubMed Web of Science ®Google Scholar
• Skerrett SJ, Niederman MS, Fein AM. Respiratory infections and acute lung injury in systemic illness. Clin Chest Med. 1989;10:469–502.
   PubMed Web of Science ®Google Scholar
• Koivula I, Sten M, Mäkelä PH. Risk factors for pneumonia in the elderly. Am J Med. 1994;96:313–320.
   PubMed Web of Science ®Google Scholar
• Fujiki R, Kawayama T, Ueyama T, et al. The risk factors for mortality of community-acquired pneumonia in Japan. J Infect Chemother. 2007;13:157–165.
   PubMedGoogle Scholar
• Zhang J, Li M, Yang Y, et al. NPR-A: a therapeutic target in inflammation and cancer. Crit Rev Eukaryot Gene Expr. 2015;25:41–46.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhao Z, Wang J. Natriuretic peptide receptor A as a novel target for cancer. World J Surg Onc. 2014;12:174.
   PubMed Web of Science ®Google Scholar
• Jacob M, Saller T, Chappell D, et al. Physiological levels of A-, B- and C-type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability. Basic Res Cardiol. 2013;108:347.
   PubMed Web of Science ®Google Scholar
• Bando S, Soeki T, Matsuura T, et al. Plasma brain natriuretic peptide levels are elevated in patients with cancer. PLoS One. 2017;12:e0178607.
   PubMed Web of Science ®Google Scholar
• LaPointe MC. Molecular regulation of the brain natriuretic peptide gene. Peptides. 2005;26:944–956.
   PubMed Web of Science ®Google Scholar
• Iseki K, Tozawa M, Yoshi S, et al. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant. 1999;14:1956–1960.
   PubMed Web of Science ®Google Scholar
• St Peter JV, Hartley GG, Murakami MM, et al. B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery. Clin Chem. 2006;52:680–685.
   PubMed Web of Science ®Google Scholar